Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04485234 · ClinicalTrials.gov registry record
Inclusive Invasive Physiological Assessment in Angina Syndromes Registry
A clinical trial of Coronary Artery Disease and Microvascular Coronary Artery Disease, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
- Completed
- Registry status
- 2,322
- Enrollment target
- 12
- Study locations
NCT04485234 is a study of Coronary Artery Disease and Microvascular Coronary Artery Disease that has completed, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The registered enrollment target is 2,322 participants, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (82% higher). The trial reports 12 study locations across 2 states.
The verdict
NCT04485234, a study of Coronary Artery Disease and Microvascular Coronary Artery Disease, has completed, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
- COMPLETED
- Registry status
- 2,322 participants
- Enrollment target
- 12
- Study locations
Study Summary
This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance
Study Locations (12)
Other
- Aarhus University Hospital - Aarhus
- Catholic University of the Sacred Heart - Roma
- Gifu Heart Center - Gifu
- Toda Central General Hospital - Toda
- Tsuchiura Kyodo General Hospital - Tsuchiura
- Amsterdam UMC - location AMC - Amsterdam
- Tergooi - Blaricum
- Amphia Hospital - Breda
- Samsung Medical Center - Seoul
- Seoul National University Hospital - Seoul
- Hospital Clinico San Carlos - Madrid
Ohio
- Cincinnati University Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,322 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2021-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04485234
The ClinicalTrials.gov registry entry for NCT04485234 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,322 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,276-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (82% higher). The listed sponsor is Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance is the first listed.
NCT04485234 reports 12 study locations spanning 2 distinct geographic areas - top geographies include Other, Ohio.
Frequently Asked Questions
What is clinical trial NCT04485234 about?
NCT04485234 is a clinical study titled "Inclusive Invasive Physiological Assessment in Angina Syndromes Registry". This study evaluates the prognostic value and potential therapeutic impact of combined pressure and flow measurements in the evaluation of epicardial coronary stenosis and microvascular function.
What is the current status of trial NCT04485234?
This trial is currently completed. The enrollment target is 2,322 participants. The study started on 2019-06-01. Estimated completion is 2021-03-25.
What conditions does trial NCT04485234 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Microvascular Coronary Artery Disease.
What interventions are being tested in trial NCT04485234?
The interventions under investigation include: Resting distal coronary to aortic pressure ratio, Fractional flow reserve, Coronary Flow Reserve, Microvascular resistance (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04485234?
This trial is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04485234 being conducted?
This trial has 12 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.